Case Report of Menopausal Woman Diagnosed with Endometrial Cancer after Colon Cancer with Germline Mutation in MSH6 in Korea

´ëÇÑÆó°æÇÐȸÁö 2017³â 23±Ç 1È£ p.69 ~ p.73

ÀÌÇöÁ¤(Lee Hyun-Jung) - CHA University CHA Bundang Medical Center Department of Obstetrics and Gynecology
À̹ÎÈñ(Lee Min-Hee) - CHA University CHA Bundang Medical Center Department of Obstetrics and Gynecology
ÃÖ¹Îö(Choi Min-Chul) - CHA University CHA Bundang Medical Center Department of Obstetrics and Gynecology
Á¤»ó±Ù(Jung Sang-Geun) - CHA University CHA Bundang Medical Center Department of Obstetrics and Gynecology
ÁÖ¿ø´ö(Joo Won-Duk) - CHA University CHA Bundang Medical Center Department of Obstetrics and Gynecology
±èÅÂÇö(Kim Tae-Heon) - CHA University CHA Bundang Medical Center Department of Pathology
ÀÌÂù(Lee Chan) - CHA University CHA Bundang Medical Center Department of Obstetrics and Gynecology
ÀåÀÚÇö(Jang Ja-Hyun) - Green Cross Genome

Abstract

We present a case of an endometrial cancer patient with germline mutation in MutS homolog 6 (MSH6), associated with Lynch syndrome. A 60-year-old Korean woman had a personal history of colon cancer 23 years ago. She also had a family history of endometrial cancer and colon cancer of her sisters and brothers. Immunohistochemistry was negative for MutL homolog 1 (MLH1) and positive for MutS homolog 2 (MSH2). Based on these findings, she underwent genetic counseling and testing that revealed a frameshift germline mutation at MSH6 (c. 3261dupC).

Å°¿öµå

Endometrial neoplasms, Germ-line mutation, Hereditary nonpolyposis, Lynch syndrome
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Approximately 3% to 5% of endometrial cancer is associated with Lynch syndrome; When affected by Lynch syndrome, the lifetime risk of endometrial canceris 16% to 60%.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå